MedTrace Logo

Quality Of Life In Colorectal Cancer Survivors

NCT07427901 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 368

Last updated 2026-02-23

No results posted yet for this study

Summary

The purpose of this study is to identify late adverse effects in colorectal cancer patients that may influence quality of life at 6, 12, and 24 months after oncological treatment. The study aims to assess quality of life in colorectal cancer survivors in relation to psycho-physical-social well-being at different time points and to evaluate the prevalence of late adverse effects and their association with diagnosis and specific oncological treatment.

Conditions

Interventions

OTHER

Quality of Life Assessment

Quality of life assessment using questionnaires at 6, 12, and 24 months after oncological treatment.

Sponsors & Collaborators

  • Institute of Oncology Ljubljana

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2024-01-01
Completion
2027-12-31

Countries

  • Slovenia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07427901 on ClinicalTrials.gov